Table 2.

Treatment details in patients with stage IIIB NSCLC - Continuous variables are displayed as median (interquartile range). Categorical variables are displayed as number (% total).

Treatment Information		CR Group n=7,459	CRS Group n=1,714	p-Value
Radiation Sequence	Pre-op	n/a	903 (53%)	n/a
	Post-op		700 (41%)
	Both		33 (2%)
	Other / Unknown		78 (4%)
Median Total Radiation Dose – cGy (Interquartile range)		6500 (6300-6840)	5940 (5040-6480)	<0.001
Chemotherapy Sequence (n=709)	Pre-op	n/a	366 (52%)	n/a
	Post-op		266 (37%)
	Both		76 (11%)
Type of Chemotherapy	Multi-agent	6,602 (86%)	1,455 (85%)	<0.001
	Single-agent	457 (6%)	78 (5%)
	Unknown	603 (8%)	181 (11%)
Surgical Margins	R0	n/a	1,218 (71%)	n/a
	R1/R2		298 (17%)
	Unknown		198 (12%)
Surgery Type	Lobectomy	n/a	1,021 (60%)	n/a
	Pneumonectomy		350 (20%)
	Wedge/segmentectomy		343 (20%)